Rossby Financial LCC Invests $654,000 in Danaher Co. (NYSE:DHR)

Rossby Financial LCC acquired a new position in shares of Danaher Co. (NYSE:DHR) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,850 shares of the conglomerate’s stock, valued at approximately $654,000.

Other large investors have also recently bought and sold shares of the company. Gilbert & Cook Inc. boosted its stake in shares of Danaher by 2.5% in the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after purchasing an additional 42 shares in the last quarter. Grimes & Company Inc. raised its holdings in Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock valued at $1,696,000 after buying an additional 43 shares during the last quarter. Dakota Community Bank & Trust NA raised its stake in Danaher by 16.4% during the fourth quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after buying an additional 45 shares during the last quarter. Howard Capital Management Group LLC lifted its holdings in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares during the period. Finally, Spinnaker Trust boosted its position in Danaher by 1.2% during the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after acquiring an additional 50 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Up 4.4 %

Shares of DHR stock opened at $188.75 on Monday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a market capitalization of $134.90 billion, a price-to-earnings ratio of 35.75, a PEG ratio of 2.66 and a beta of 0.86. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a 50-day simple moving average of $203.71 and a two-hundred day simple moving average of $229.58.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm earned $2.09 earnings per share. Research analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.68%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s payout ratio is presently 24.24%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on DHR. Guggenheim initiated coverage on Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Raymond James reiterated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Robert W. Baird cut their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a research note on Friday, March 14th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Four investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $276.57.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.